SCHEMBL3597289

SCHEMBL3597289

O=C(Cn1ccc2cccc(-c3ccccc3)c21)NCCNCC1CCCCC1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.41
HSD17B10 Q99714 2/20 0.41
MAPK1 P28482 1/20 0.41
EPHX2 P34913 1/20 0.41
KDM4E B2RXH2 3/20 0.41
LMNA P02545 2/20 0.41
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
TDP1 Q9NUW8 1/20 0.40
HTT P42858 2/20 0.40
MAPT P10636 1/20 0.40
SMN1; SMN2 Q16637 2/20 0.39
TP53 P04637 1/20 0.39
TSHR P16473 1/20 0.39
NPSR1 Q6W5P4 2/20 0.39
NPY5R Q15761 1/20 0.39
PLA2G1B P04054 1/20 0.37
ATM Q13315 1/20 0.37
ATG4B Q9Y4P1 1/20 0.37
EPHX1 P07099 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3594707 0.91 NPC1 (0.41) ALDH1A1HSD17B10MAPK1KDM4ELMNA
SCHEMBL3608260 0.91 GRIN2B (0.42) ALDH1A1HSD17B10MAPK1KDM4ELMNA
SCHEMBL3589653 0.91 ROCK2 (0.38) ALDH1A1HSD17B10MAPK1EPHX2KDM4E
SCHEMBL3608180 0.91 HTT (0.45) ALDH1A1HSD17B10MAPK1EPHX2KDM4E
SCHEMBL3605994 0.90 PIM1 (0.42) ALDH1A1HSD17B10MAPK1KDM4EMEN1
SCHEMBL3592317 0.90 KDM4E (0.41) ALDH1A1HSD17B10MAPK1KDM4ELMNA
SCHEMBL3605921 0.89 EPHX2 (0.41) ALDH1A1EPHX2KDM4EMEN1KMT2A
SCHEMBL3605625 0.89 MGLL (0.38) ALDH1A1HSD17B10MAPK1EPHX2KDM4E
SCHEMBL3596540 0.89 HSD17B10 (0.37) ALDH1A1HSD17B10MAPK1EPHX2KDM4E
SCHEMBL3595323 0.87 ALDH1A1 (0.44) ALDH1A1HSD17B10MAPK1KDM4EKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7807704-B2 Bicyclic, nitrogen-containing compounds modulating CXCR4 and/or CCXCKR2 CHEMOCENTRYX, INC. (US) 2010-10-05 US disclosed
US-20070275965-A1 CXCR4 modulators CHEMOCENTRYX, INC. (US) 2007-11-29 US disclosed
WO-2007115231-A2 CXCR4 MODULATORS CHEMOCENTRYX, INC. (US) 2007-10-11 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070275965-A1 CXCR4 modulators CXCL12, CXCR4, CXCR1 ALDH1A1 662/4885HSD17B10 3413/4885MAPK1 1264/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.